Riverpark Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-38,868
Closed -$5.22M 32
2021
Q4
$5.22M Sell
38,868
-13,500
-26% -$1.94M 1.88% 33
2021
Q3
$7.16M Sell
52,368
-10,292
-16% -$1.3M 2.53% 17
2021
Q2
$6.69M Hold
62,660
2.66% 14
2021
Q1
$5.63M Sell
62,660
-1,184
-2% -$111K 2.52% 18
2020
Q4
$5.9M Buy
63,844
+21,992
+53% +$1.96M 2.66% 18
2020
Q3
$4.31M Buy
41,852
+24,380
+140% +$2.55M 2.28% 24
2020
Q2
$1.77M Sell
17,472
-17,080
-49% -$1.53M 2.46% 19
2020
Q1
$2.33M Buy
+34,552
New +$2.15M 3.1% 16

Other funds holding DXCM

Riverpark Capital Management's DXCM Position: Q1 2022 in Review

Riverpark Capital Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 38,868 shares — an estimated $5.22M sold.

Riverpark Capital Management first reported a position in DXCM in Q1 2020 and held it in 8 quarters. The position peaked at $7.16M in Q3 2021. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Riverpark Capital Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Riverpark Capital Management sold 38,868 DexCom shares in Q1 2022, an estimated $5.22M.
  • Riverpark Capital Management first reported a position in DexCom in Q1 2020 and held it in 8 quarters.
  • Riverpark Capital Management's DexCom position peaked at $7.16M in Q3 2021.
  • 862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Riverpark Capital Management's 13F filing for Q1 2022, filed 9 May 2022.